Using the Travel Cost Method to Value Visits and Stigma in Connection with ARV Adherence in Uganda

Applied Economics, 49:5, 477-497, 2017; DOI: 10.1080/00036846.2016.1200185

Posted: 21 Sep 2018

Date Written: 2017

Abstract

This article uses the travel cost method to value both client visits to collect antiretroviral therapy (ARV) and stigma, which prevents ARV adherence. Using a representative sample for Uganda initiated specifically for this study, we found a willingness to pay (WTP) valuation for visits made in the range of US$14–US$17 and a willingness to accept (WTA) valuation of US$25 for visits missed. The valuations for stigma based on a novel measure of stigma using a new estimation method were close to the valuations for visits. These valuations can be used to estimate the benefits to carry out cost–benefit analyses (CBAs) of interventions aimed at increasing ARV coverage and adherence.

Keywords: Travel Cost Method; Antiretrovirals for HIV; Stigma

JEL Classification: H42; I11; D61

Suggested Citation

Brent, Robert J, Using the Travel Cost Method to Value Visits and Stigma in Connection with ARV Adherence in Uganda (2017). Applied Economics, 49:5, 477-497, 2017; DOI: 10.1080/00036846.2016.1200185, Available at SSRN: https://ssrn.com/abstract=3241014

Robert J Brent (Contact Author)

Fordham University ( email )

Department of Economics
441 E Fordham Road
Bronx, NY 10458
United States
718 817 4058 (Phone)

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Abstract Views
139
PlumX Metrics